- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate cancer vaccines: the long road to clinical application
Authors
Keywords
Prostate cancer, Cancer vaccines, Immunomodulation, Epitope spreading, Cross-presentation, Biomarkers
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 64, Issue 4, Pages 401-408
Publisher
Springer Nature
Online
2015-02-18
DOI
10.1007/s00262-015-1667-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Radiation-Induced Modulation of Costimulatory and Coinhibitory T-Cell Signaling Molecules on Human Prostate Carcinoma Cells Promotes Productive Antitumor Immune Interactions
- (2014) Michael B. Bernstein et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and prediction
- (2014) Sonia A. Perez et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates
- (2014) Caroline Jochems et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tyrosine kinase inhibitors in the treatment of prostate cancer: taking the next step in clinical development
- (2014) Michelle A Ojemuyiwa et al. EXPERT OPINION ON EMERGING DRUGS
- Immune-checkpoint inhibitors march on, now in combinations
- (2014) Cormac Sheridan NATURE BIOTECHNOLOGY
- Castration-resistant prostate cancer: latest evidence and therapeutic implications
- (2014) Daniel L. Suzman et al. Therapeutic Advances in Medical Oncology
- AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial
- (2013) Sonia A. Perez et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combination Therapy with a Second-Generation Androgen Receptor Antagonist and a Metastasis Vaccine Improves Survival in a Spontaneous Prostate Cancer Model
- (2013) A. Ardiani et al. CLINICAL CANCER RESEARCH
- Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
- (2013) James W. Hodge et al. INTERNATIONAL JOURNAL OF CANCER
- Complete Biochemical (Prostate-specific Antigen) Response to Sipuleucel-T With Enzalutamide in Castration-resistant Prostate Cancer: A Case Report With Implications for Future Research
- (2013) Julie N. Graff et al. UROLOGY
- Harnessing the Potential of Radiation-Induced Immune Modulation for Cancer Therapy
- (2013) M. M. Ahmed et al. Cancer Immunology Research
- Immune Responses to Cancer: Are They Potential Biomarkers of Prognosis?
- (2013) Theresa L. Whiteside Frontiers in Oncology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Increasing the efficacy of tumor cell vaccines by enhancing cross priming
- (2012) Brian M. Andersen et al. CANCER LETTERS
- Combining immunological and androgen-directed approaches
- (2012) Emmanuel S. Antonarakis et al. CURRENT OPINION IN ONCOLOGY
- Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis
- (2012) Benjamin Weide et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic Cancer Vaccines: Current Status and Moving Forward
- (2012) J. Schlom JNCI-Journal of the National Cancer Institute
- Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
- (2012) Ravi A Madan et al. LANCET ONCOLOGY
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
- (2011) Mary L. Disis CANCER IMMUNOLOGY IMMUNOTHERAPY
- Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines
- (2011) Marijo Bilusic et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Impact of tumour volume on the potential efficacy of therapeutic vaccines
- (2011) J. L. Gulley et al. Current Oncology
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Tumor Regression and Growth Rates Determined in Five Intramural NCI Prostate Cancer Trials: The Growth Rate Constant as an Indicator of Therapeutic Efficacy
- (2010) W. D. Stein et al. CLINICAL CANCER RESEARCH
- CD8α+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor
- (2010) Alison M. McDonnell et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Improved Endpoints for Cancer Immunotherapy Trials
- (2010) A. Hoos et al. JNCI-Journal of the National Cancer Institute
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant
- (2008) R. J. Lechleider et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started